作者：
Esmeralda,Alvarado-Facundo [1]
;
Rachel,Herrup [1]
;
Wei,Wang [1]
;
Rhonda E,Colombo [2]
;
Limone,Collins [3]
;
Anuradha,Ganesan [4]
;
David,Hrncir [3]
;
Tahaniyat,Lalani [5]
;
Ana Elizabeth,Markelz [6]
;
Ryan C,Maves [7]
;
Bruce,McClenathan [3]
;
Katrin,Mende [8]
;
Stephanie A,Richard [9]
;
Kat,Schmidt [9]
;
Christina,Schofield [10]
;
Srihari,Seshadri [3]
;
Christina,Spooner [3]
;
Christian L,Coles [9]
;
Timothy H,Burgess [11]
;
Carol D,Weiss [1]
;
Maryna,Eichelberger [12]
作者单位：
Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
[1]
Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA; Madigan Army Medical Center, Tacoma, WA, USA; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
[2]
Immunization Healthcare Division, Defense Health Agency, Bethesda, MD, Falls Church, VA, Fort Liberty, NC, and San Diego, CA, USA.
[3]
Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA; Walter Reed National Military Medical Center, Bethesda, MD, USA.
[4]
Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA; Naval Medical Center Portsmouth, Portsmouth, VA, USA.
[5]
Brooke Army Medical Center, San Antonio, TX, USA.
[6]
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Naval Medical Center San Diego, San Diego, CA, USA; Wake Forest University School of Medicine, Winston-Salem, NC, USA.
[7]
Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA; Brooke Army Medical Center, San Antonio, TX, USA.
[8]
Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.
[9]
Madigan Army Medical Center, Tacoma, WA, USA; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
[10]
Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
[11]
Center for Biologics Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. Electronic address: Maryna.Eichelberger@fda.hhs.gov.
[12]
主题词
流感疫苗(Influenza Vaccines);神经氨酸酶(Neuraminidase);人类(Humans);抗体, 病毒(Antibodies, Viral);抗体, 中和(Antibodies, Neutralizing);流感, 人(Influenza, Human);流感病毒A型, H3N2亚型(Influenza A Virus, H3N2 Subtype);女(雌)性(Female);流感病毒A型, H1N1亚型(Influenza A Virus, H1N1 Subtype);成年人(Adult);男(雄)性(Male);疫苗, 灭活(Vaccines, Inactivated);青年人(Young Adult);中年人(Middle Aged);青少年(Adolescent);抗体生成(Antibody Formation);血凝素糖蛋白类, 流感病毒(Hemagglutinin Glycoproteins, Influenza Virus);接种(Vaccination)
DOI
10.1016/j.vaccine.2024.126669
PMID
39754936
发布时间
2025-01-20
换一批
换一批
